 |
GlaxoSmithKline Hepatitis B Help, |
 |
| Site Map |
Hepatitis B
Patient Information
| Find answers to common questions about hepatitis B and learn about hepatitis B treatments such as EPIVIR-HBV (lamivudine). | ||
|
Healthcare
Professionals
| Review recent hepatitis B treatment research and locate upcoming conference events. | ||
|
Hepatitis B
Media Center
| Get facts on hepatitis B and EPIVIR-HBV (lamivudine). | ||
|
EPIVIR-HBV is indicated for the treatment of chronic hepatitis B
associated with viral replication and active liver inflammation in adults and
children 2-17 years.
This site is intended for US residents only.
© 1997-2008 GlaxoSmithKline. All Rights Reserved.
Legal Notices | Privacy Statement | Medicine Savings | Contact Us
associated with viral replication and active liver inflammation in adults and
children 2-17 years.
Please see additional important information about
EPIVIR-HBV® (lamivudine).
[Requires Adobe Acrobat Reader - click here to download]
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
This site is intended for US residents only.
© 1997-2008 GlaxoSmithKline. All Rights Reserved.